Heparan sulfate is a plasma biomarker of acute cellular allograft rejection

• Andrew S. Barbas ,

  Contributed equally to this work with: Andrew S. Barbas, Liwen Lin

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  * E-mail: andrew.barbas@duke.edu

  Affiliation Department of Surgery, Duke University Medical Center, Durham, NC, United States of America

  http://orcid.org/0000-0003-3476-2313

  ⨯
• Liwen Lin ,

  Contributed equally to this work with: Andrew S. Barbas, Liwen Lin

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology

  Affiliation Department of Surgery, Duke University Medical Center, Durham, NC, United States of America

  ⨯
• MacKenzie McRae,

  Roles Data curation, Investigation

  Affiliation Department of Surgery, Duke University Medical Center, Durham, NC, United States of America

  ⨯
• Andrea L. MacDonald,

  Roles Data curation, Formal analysis, Investigation

  Affiliation Department of Surgery, Duke University Medical Center, Durham, NC, United States of America

  ⨯
• Tracy Truong,

  Roles Data curation, Formal analysis

  Affiliation Department of Surgery, Duke University Medical Center, Durham, NC, United States of America

  ⨯
• Yiping Yang,

  Roles Conceptualization, Resources, Supervision

  Affiliation Department of Medicine, Duke University Medical Center, Durham, NC, United States of America

  ⨯
• Todd V. Brennan

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America

  ⨯